Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Rachel Neuwirth"'
Autor:
Mark van Duin, Annemiek Broyl, Yvonne de Knegt, Hartmut Goldschmidt, Paul G. Richardson, Wim C. J. Hop, Bronno van der Holt, Debora Joseph-Pietras, George Mulligan, Rachel Neuwirth, Surinder S. Sahota, Pieter Sonneveld
Publikováno v:
Haematologica, Vol 96, Iss 11 (2011)
Background In multiple myeloma, expression of cancer testis antigens may provide prognostic markers and potential targets for immunotherapy. Expression at relapse has not yet been evaluated for a large panel of cancer testis antigens which can be cla
Externí odkaz:
https://doaj.org/article/90a566bd7eed46f486fe80674abf113d
Publikováno v:
Sleep Medicine. 107:229-235
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24a4b728e4bce886a060b81276f67461
https://doi.org/10.1016/j.sleep.2023.05.001
https://doi.org/10.1016/j.sleep.2023.05.001
Autor:
Arijit Chakravarty, Karthik Venkatakrishnan, Rachael Brake, Natasha Iartchouk, Rachel Neuwirth, Chirag Patel, Jilai Zhou, Ekta Kadakia, Mayankbhai Patel, Dean C. Bottino
Supplementary Methods, Figures S1-5, and Tables S1-3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b088fa39511bd74eaedb270218472df5
https://doi.org/10.1158/1078-0432.22472366
https://doi.org/10.1158/1078-0432.22472366
Autor:
Franziska Michor, Michael H. Tomasson, Paul G. Richardson, Jesús F. San Miguel, Irene M. Ghobrial, Kenneth Anderson, Dixie-Lee Esseltine, Rachel Neuwirth, Suzanne Viselli, Constantine Mitsiades, Jennifer G. Tross, Helgi van de Velde, Rui Zhao, Min Tang
Supplementary Information
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b357d3ef1c1dd6499f7a8c43f3a6d5a
https://doi.org/10.1158/1078-0432.22463124
https://doi.org/10.1158/1078-0432.22463124
Autor:
Dennis Slamon, E. Jane Leonard, Sylvie Vincent, Kevin Galinsky, Rachel Neuwirth, Jingjing Chen, Eva Carrasco, Antonio Antón, Jose L. Alonso-Romero, Manuel Ramos, Nieves Ferrer, Santiago González-Santiago, Ainhara Lahuerta, Yolanda Jerez, Ricardo Cubedo, Noelia Martínez-Jáñez, José Á. García-Sáenz
Purpose:This phase II study investigated daily or weekly sapanisertib (a selective dual inhibitor of mTOR complexes 1 and 2) in combination with fulvestrant.Patients and Methods:Postmenopausal women with estrogen receptor–positive (ER+)/HER2-negati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::630979ea079a2e71f3253cb232b8dad2
https://doi.org/10.1158/1078-0432.c.6531135
https://doi.org/10.1158/1078-0432.c.6531135
Autor:
Franziska Michor, Michael H. Tomasson, Paul G. Richardson, Jesús F. San Miguel, Irene M. Ghobrial, Kenneth Anderson, Dixie-Lee Esseltine, Rachel Neuwirth, Suzanne Viselli, Constantine Mitsiades, Jennifer G. Tross, Helgi van de Velde, Rui Zhao, Min Tang
Supplementary Table S1. Summary statistics of the estimated slopes and turning points for the model fitting of the six cohorts from the three trials. Supplementary Table S2. Information on the number of data points in the pre-treatment phase, phase d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cbd1436651610a4c2924a15d3737141
https://doi.org/10.1158/1078-0432.22463127.v1
https://doi.org/10.1158/1078-0432.22463127.v1
Autor:
Arijit Chakravarty, Karthik Venkatakrishnan, Rachael Brake, Natasha Iartchouk, Rachel Neuwirth, Chirag Patel, Jilai Zhou, Ekta Kadakia, Mayankbhai Patel, Dean C. Bottino
Purpose:Recommended phase II dose (RP2D) determination for combination therapy regimens is a constrained optimization problem of maximizing antitumor activity within the constraint of clinical tolerability to provide a wide therapeutic index. A metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1697e4d2a6132b6b742a4af840721a2e
https://doi.org/10.1158/1078-0432.c.6528203.v1
https://doi.org/10.1158/1078-0432.c.6528203.v1
Autor:
Dennis Slamon, E. Jane Leonard, Sylvie Vincent, Kevin Galinsky, Rachel Neuwirth, Jingjing Chen, Eva Carrasco, Antonio Antón, Jose L. Alonso-Romero, Manuel Ramos, Nieves Ferrer, Santiago González-Santiago, Ainhara Lahuerta, Yolanda Jerez, Ricardo Cubedo, Noelia Martínez-Jáñez, José Á. García-Sáenz
Supplementary Figure from Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor–Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::030af923744a0f4a65becbf504ff188d
https://doi.org/10.1158/1078-0432.22483416
https://doi.org/10.1158/1078-0432.22483416
Autor:
Franziska Michor, Michael H. Tomasson, Paul G. Richardson, Jesús F. San Miguel, Irene M. Ghobrial, Kenneth Anderson, Dixie-Lee Esseltine, Rachel Neuwirth, Suzanne Viselli, Constantine Mitsiades, Jennifer G. Tross, Helgi van de Velde, Rui Zhao, Min Tang
Supplementary Figure S1. Demonstration of exponential curves and corresponding linear curves after log-transforming the original data. Supplementary Figure S2. Baseline values for the analysis of disease dynamics during treatment. Supplementary Figur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a03408c73ff68452f624cda10729538
https://doi.org/10.1158/1078-0432.22463130
https://doi.org/10.1158/1078-0432.22463130
Autor:
Franziska Michor, Michael H. Tomasson, Paul G. Richardson, Jesús F. San Miguel, Irene M. Ghobrial, Kenneth Anderson, Dixie-Lee Esseltine, Rachel Neuwirth, Suzanne Viselli, Constantine Mitsiades, Jennifer G. Tross, Helgi van de Velde, Rui Zhao, Min Tang
Purpose: Since the pioneering work of Salmon and Durie, quantitative measures of tumor burden in multiple myeloma have been used to make clinical predictions and model tumor growth. However, such quantitative analyses have not yet been performed on l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ba2851c3769d4ff4d4ec12a44b85b46
https://doi.org/10.1158/1078-0432.c.6525315.v1
https://doi.org/10.1158/1078-0432.c.6525315.v1